AGL today
$110.57-$4.24 (-3.69%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourBearish
1 hourDescending Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $167.50
Key levels
Resistance$125.71
Resistance$118.25
Support$103.88
Support$94.20
Latest news & SEC filings
AnalystStoneX keeps Buy rating on Agilon Health, lifts target to $145
AnalystEvercore ISI Group lifts its price target on agilon health
All AGL news →About agilon health
agilon health works with primary care doctor groups to oversee the full range of care for Medicare patients. It sets up risk-bearing entities that receive monthly payments from health plans to cover members' medical needs, and partners with anchor physician groups through long-term service agreements. The company operates in local markets across the United States, serving Medicare Advantage members and traditional government-insured seniors.
Based on the company's 10-K filed Feb 25, 2026.
NYSE · Healthcare
agilon health, inc. (AGL)
What Is the Price Target for AGL?
SEPT Low Target
$94.77
SEPT Mid Target
$111.50
SEPT High Target
$128.22
Analyst Consensus
$111.50
Is AGL a Buy or Sell Right Now?
Thesis
- •Revenue growing -2.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AGL.
Start Free Trial →Is AGL Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$83.99
13
Moat Score
NONE
2/9
Piotroski Score
19.6
Altman Z-Score
What Is Smart Money Doing with AGL?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Wulf John William | director | Buy | 2,133 | - | Jun 2, 2026 |
| WILLIAMS RONALD A | director | Buy | 2,133 | - | Jun 2, 2026 |
| McLoughlin Karen | director | Buy | 2,133 | - | Jun 2, 2026 |
| MCKENZIE DIANA | director | Buy | 2,133 | - | Jun 2, 2026 |
| Mansukani Sharad | director | Buy | 2,133 | - | Jun 2, 2026 |
| Battaglia Silvana | director | Buy | 2,133 | - | Jun 2, 2026 |
| Zamore Denise | officer | Sale | 485 | $45K | Jun 1, 2026 |
| Gertsch Timothy | officer | Sale | 8 | $691.12 | May 24, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AGL Growth Story
Revenue YoY
-2.1%
3yr Revenue CAGR
35.4%
EPS Growth YoY
N/A
FCF Growth YoY
-67.5%
Revenue Trend
STRONG
Dark Pool Trades for AGL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AGL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:17 | $114.81 | 2,301 | $$264K | SELL |
| 17:30:06 | $114.59 | 2,285 | $$262K | BUY |
| 16:39:41 | $113.53 | 1,500 | $$170K | SELL |
| 21:00:26 | $113.52 | 1,681 | $$191K | BUY |
| 16:31:42 | $112.31 | 2,145 | $$241K | BUY |
5 dark pool trades shown · $$1.1M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for agilon health, inc. (AGL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AGL — frequently asked questions
What is AGL stock price today?
agilon health, inc. (AGL) is at $110.57, down 3.69% (-$4.24) at the Nov 12, 2026 close.
Why is AGL stock moving today?
Latest AGL news — Nov 11, 2026: StoneX keeps Buy rating on Agilon Health, lifts target to $145 · Nov 6, 2026: Evercore ISI Group lifts its price target on agilon health
What is the AGL price target?
The average analyst price target for AGL is $111.50, ranging from $35 to $146, based on 12 analysts. Latest: Bernstein upgrade on Sep 15, 2026.
What do analysts rate AGL?
Analyst ratings for AGL: 4 Buy, 13 Hold, 3 Sell — consensus Hold.
Did AGL beat earnings?
AGL last reported on Aug 5, 2026: EPS $1.04 vs $0.14 expected — a beat of 622.2%.
Does AGL pay a dividend?
AGL does not currently pay a dividend.
What are AGL support and resistance levels?
Support: $103.88, $94.20, $82.24. Resistance: $118.25, $125.71, $133.04.
What are insiders doing with AGL?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on AGL?
Nov 11, 2026: StoneX keeps Buy rating on Agilon Health, lifts target to $145 · Nov 6, 2026: Evercore ISI Group lifts its price target on agilon health